Growth Strategies Case Study

Growth Strategies of Ranbaxy

OR

Abstract:
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, reached the $1 billion mark in global sales – a target that it had set for itself in 1993. Ranbaxy is among the top ten generics companies in the world with a strong presence in bulk drugs and branded formulations.

Pedagogical Objectives:

• To discuss the growth strategies of Ranbaxy that catapulted it to a prominent position on the global pharmaceutical map
• To discuss the company's initiative to sustain its leadership in the light of the product patents being recognised from 2005 onwards according to the World Trade Organisation regulations.

Keywords : Ranbaxy Laboratories Limited; Global generics market; Active pharmaceutical ingredients; Ranbaxy Nigeria Limited; Abbreviated new drug application (ANDA); Novel drug delivery system (NDDS); New drug discovery research (NDDR); Controlled drug release technology; Proprietary prescription products; Product patents in India after 2005; Indian Patents Act 1970; Growth Strategies Case Study; Branded generics market; National Institute of Pharmaceutical Education and Research (India); Once-a-day cirpofloxacin; General Agreement on Tariffs and Trade (GATT)

Contents : 
Growth Strategies
Research & Development
Future Prospects
The World of Ranbaxy
Market-wise Business Distribution of Ranbaxy
Patents Regime 2005 Under TRIPS
The Vision of Ranbaxy